Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Regional Medical Center
mi
from
Paterson, NJ
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Regional Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
The Valley Hospital
mi
from
Ridgewood, NJ
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Presbyterian Hospital
mi
from
Albuquerque, NM
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Presbyterian Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Hospital Health Center
mi
from
Liverpool, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital Health Center
mi
from
Liverpool, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Long Island Jewish Medical Center
mi
from
Manhasset, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Long Island Jewish Medical Center
mi
from
Manhasset, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital
mi
from
Mineola, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital-Cornell University
mi
from
New York, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital-Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Lenox Hill Hospital
mi
from
New York, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Strong Memorial Hospital
mi
from
Rochester, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Strong Memorial Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center - Pineville
mi
from
Charlotte, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center - Pineville
mi
from
Charlotte, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Presbyterian Hospital
mi
from
Charlotte, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Presbyterian Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
WakeMed
mi
from
Raleigh, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
WakeMed
mi
from
Raleigh, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Novant Health Forsyth Medical Center
mi
from
Winston-Salem, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Novant Health Forsyth Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Aultman Hospital
mi
from
Canton, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Aultman Hospital
mi
from
Canton, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
The University Hospital
mi
from
Cincinnati, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
The University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
The Christ Hospital
mi
from
Cincinnati, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Tri-Health Good Samaritan Hospital
mi
from
Cincinnati, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Tri-Health Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Bethesda North Hospital
mi
from
Cincinnati, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Riverside Methodist Hospital
mi
from
Columbus, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
EMH Healthcare
mi
from
Elyria, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
EMH Healthcare
mi
from
Elyria, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Cleveland Cln Fairview Hospital
mi
from
Fairview Park, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Cleveland Cln Fairview Hospital
mi
from
Fairview Park, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Kettering Medical Center
mi
from
Kettering, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Kettering Medical Center
mi
from
Kettering, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Toledo Hospital
mi
from
Toledo, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Mercy St. Vincent's Medical Center
mi
from
Toledo, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Mercy St. Vincent's Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Hillcrest Medical Center
mi
from
Tulsa, OK
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Hillcrest Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Providence St. Vincent Medical Center
mi
from
Portland, OR
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Providence St. Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
PeaceHealth Sacred Heart Medical Center
mi
from
Springfield, OR
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
PeaceHealth Sacred Heart Medical Center
mi
from
Springfield, OR
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Holy Spirit Hospital
mi
from
Camp Hill, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Holy Spirit Hospital
mi
from
Camp Hill, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Doylestown Hospital
mi
from
Doylestown, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
UPMC Hamot
mi
from
Erie, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
UPMC Hamot
mi
from
Erie, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Mary Medical Center
mi
from
Langhorne, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Mary Medical Center
mi
from
Langhorne, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Forbes Hospital
mi
from
Monroeville, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Forbes Hospital
mi
from
Monroeville, PA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials